Entera Bio Ltd (ENTX) Social Stream



Entera Bio Ltd (ENTX): $1.54

0.01 (-0.65%)

POWR Rating

Component Grades

Momentum

C

Stability

D

Sentiment

Quality

F

Add ENTX to Watchlist
Sign Up

Industry: Biotech

Industry

NR

Ranked

#446 of 481

in industry

ENTERA BIO LTD (ENTX) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering ENTX.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2022-01-06 2 $12 $10 $11 $0.685 1505.84%
2022-03-09 2 $12 $6 $9.333 $0.685 1262.48%
2022-05-19 3 $9 $6 $7 $0.685 921.9%
2022-07-19 3 $9 $5 $6.666 $0.685 873.14%
2022-11-15 3 $10 $6 $8.333 $0.685 1116.5%
2022-11-18 3 $10 $2 $7 $0.685 921.9%
2023-04-04 2 $10 $2 $7 $0.685 921.9%
2023-05-08 1 $10 $2 $7 $0.685 921.9%
2023-09-11 1 $10 $2 $6 $0.685 775.91%
2023-12-11 1 $10 $10 $10 $0.685 1359.85%

The Trend in the Analyst Price Target


Over the past 28 months, ENTX's average price target has gone down $2.

Over the past 37 weeks, ENTX's average upside potential has been 825.92%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-03-28 2 10 2 7 1.063 558.51%
2023-04-04 2 10 2 7 0.980 614.29%
2023-05-08 1 10 2 7 0.880 695.45%
2023-09-11 1 10 10 10 0.669 1394.77%
2023-12-11 1 10 10 10 0.689 1351.38%

ENTX Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 1 0 0 0 0 1

The Trend in the Broker Recommendations


Over the past 17 months, ENTX's average broker recommendation rating improved by 0.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • In the context of all US stocks, ENTERA BIO LTD's upside potential (average analyst target price relative to current price) is greater than 1362.13% of them.
  • In the context of all US stocks, ENTERA BIO LTD's number of analysts covering the stock is higher than 51.05% of them.
  • In terms of how ENTERA BIO LTD fares relative to all US stocks, note that its average analyst price target is higher than 113.45% of that group.
  • ENTERA BIO LTD's variance in analysts' estimates is lower than -867.59% of stocks in the micro market cap category.

In the Pharmaceutical Products industry, GENE, TARA, and TCON are the three stocks most similar to ENTERA BIO LTD regarding the price target and analyst recommendation information presented here.

What is the outlook for ENTX? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!